Findel down after cautious update
Findel, the home shopping and education materials supplier, took a hit after the firm said it was yet to see a sustained Christmas pick-up and was cautious about the remainder of the year.
Findel, the home shopping and education materials supplier, took a hit after the firm said it was yet to see a sustained Christmas pick-up and was cautious about the remainder of the year.
However, the firm said in the last six months it had made progress with its turnaround plan.
Overall revenue grew 8.1% to £275.1m over the period, while the company pared its loss before tax by £1m to £4.6m.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It added that current trading since the end of the period had been "broadly encouraging" with the eight weeks to 23 November seeing sales 7.7% above the previous year.
The firm has been forced to set aside £4.8m for the mis-selling of payment protection insurance by its Express Gifts business, of which £1.0m has already been refunded to affected customers during the year.
Sales at the Express Gifts division increased 18.1% in the half to £110.1m, while Kleeneze sales fell 7.1% to £24.4m.
Kitbag sales rose 11.9% to £33.7m, with its healthcare business seeing sales up 13.4% to £43.4m.
Sales at its Education supplies division were down 5.3% to £59.2m .
Chief Executive, Roger Siddle, said the group's focus was on continuing to drive forwards its turnaround plan, to maintain this trend of improving results into the second half and beyond, with the clear aim of delivering improved shareholder returns over the medium term.
"Notwithstanding on-going pressure from reduced consumer spending and cost inflation, we believe we are well placed to continue to deliver on our plans," he said.
Shares were down 13.5% at 10:45 following the announcement.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published